An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients

被引:19
|
作者
Zhu, Gongmin [1 ,2 ]
Xia, Hongwei [1 ,2 ]
Tang, Qiulin [1 ,2 ]
Bi, Feng [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Canc Ctr, Dept Abdominal Oncol, 37 Guoxue Lane, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Lab Mol Targeted Therapy Oncol, 37 Guoxue Lane, Chengdu 610041, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Epithelial-mesenchymal transition; Hepatocellular carcinoma; Prognostic signature; PDCD6; TCGA;
D O I
10.1186/s12935-021-01864-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundTumor metastasis is one of the leading reasons of the dismal prognosis of hepatocellular carcinoma (HCC). Epithelial-mesenchymal transition (EMT) is closely associated with tumor metastasis including HCC. The purpose of this study is to construct and validate an EMT-related gene signature for predicting the prognosis of HCC patients.MethodsGene expression data of HCC patients was downloaded from The Cancer Genome Atlas (TCGA) database. Gene set enrichment analysis (GSEA) was performed to found the EMT-related gene sets which were obviously distinct between normal samples and paired HCC samples. Cox regression analysis was used to develop an EMT-related prognostic signature, and the performance of the signature was evaluated by Kaplan-Meier curves and time-dependent receiver operating characteristic (ROC) curves. A nomogram incorporating the independent predictors was established. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression levels of the hub genes in HCC cell lines, and the role of PDCD6 in the metastasis of HCC was determined by functional experiments.ResultsAn EMT-related 5-gene signature (PDCD6, TCOF1, TRIM28, EZH2 and FAM83D) was constructed using univariate and multivariate Cox regression analysis. Based on the signature, the HCC patients were classified into high- and low-risk groups, and patients in high-risk group had a poor prognosis. Time-dependent ROC and Cox regression analyses suggested that the signature could predict HCC prognosis exactly and independently. The predictive capacity of the signature was also validated in two external cohorts. GSEA results showed that many cancer-related signaling pathways such as PI3K/Akt/mTOR pathway and TGF-beta /SMAD pathway were enriched in high-risk group. The result of qRT-PCR revealed that PDCD6, TCOF1 and FAM83D were highly expressed in HCC cancer cells. Among them, PDCD6 were found to promote cell migration and invasion.ConclusionThe EMT-related 5-gene signature can serve as a promising prognostic biomarker for HCC patients and may provide a novel mechanism of HCC metastasis.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] An Epithelial-Mesenchymal Transition-Related LncRNA Signature Predicts Prognosis in Triple-Negative Breast Cancer
    Chen, Xuezhang
    Chen, Xikang
    Zhu, Zhixia
    Chen, Yinsong
    Pang, Xiaoqi
    Zhong, Xianxun
    You, Shuang
    Chen, Yaoxu
    Tian, Huaqin
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (02): : 1063 - 1073
  • [22] Systematic establishment and verification of an epithelial-mesenchymal transition gene signature for predicting prognosis of oral squamous cell carcinoma
    Ai, Jun
    Tan, Yaqin
    Liu, Bo
    Song, Yuhong
    Wang, Yanqin
    Xia, Xin
    Fu, Qicheng
    FRONTIERS IN GENETICS, 2023, 14
  • [23] Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment
    Gao, Biao
    Wang, Yafei
    Lu, Shichun
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23 (01)
  • [24] Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients
    Liu, Jinhui
    Cui, Guoliang
    Shen, Shuning
    Gao, Feng
    Zhu, Hongjun
    Xu, Yinghua
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [25] Epithelial-mesenchymal transition-related long noncoding RNAs in gastric carcinoma
    Feng, Ying-Nan
    Li, Bo-Ya
    Wang, Ke
    Li, Xiao-Xi
    Zhang, Lan
    Dong, Xian-Zhe
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [26] Identification of a Twelve Epithelial-Mesenchymal Transition-Related lncRNA Prognostic Signature in Kidney Clear Cell Carcinoma
    Xia, Qi-Dong
    Zhang, Yuan
    Li, Li-Sha
    Lu, Jun-Lin
    Xun, Yang
    Sun, Jian-Xuan
    Xu, Jin-Zhou
    Liu, Chen-Qian
    Lu, Yu-Chao
    He, Deng
    Wang, Shao-Gang
    DISEASE MARKERS, 2022, 2022
  • [27] A novel epithelial-mesenchymal transition-related lncRNA signature predicts prognosis and immune status in endometrioid endometrial cancer
    Jin, Yichao
    Qiu, Yixuan
    Li, Yujing
    Jiang, Ziwei
    Hu, Siwen
    Dai, Huihua
    MEDICINE, 2023, 102 (26) : E34126
  • [28] A novel epithelial–mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma
    Yanlong Shi
    Jingyan Wang
    Guo Huang
    Jun Zhu
    Haokun Jian
    Guozhi Xia
    Qian Wei
    Yuanhai Li
    Hongzhu Yu
    Hepatology International, 2022, 16 : 906 - 917
  • [29] Development of epithelial-mesenchymal transition-related lncRNA signature for predicting survival and immune microenvironment in pancreatic cancerwithexperiment validation
    Gao, Yong
    Liu, Jinhui
    Cai, Baobao
    Chen, Qun
    Wang, Guangfu
    Lu, Zipeng
    Jiang, Kuirong
    Miao, Yi
    BIOENGINEERED, 2021, 12 (02) : 10553 - 10567
  • [30] Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma
    Zhou, Yongjie
    Wang, Liangwen
    Zhang, Wen
    Ma, Jingqin
    Zhang, Zihan
    Yang, Minjie
    Yu, Jiaze
    Luo, Jianjun
    Yan, Zhiping
    DISEASE MARKERS, 2022, 2022